{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:07:00Z","timestamp":1795021620965,"version":"4.10.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","jaapos.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jaapos.2024.103959","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T17:17:56Z","timestamp":1719508676000},"page":"103959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The effect of teprotumumab infusion on ocular alignment in patients with symptomatic thyroid eye disease"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1257-0476","authenticated-orcid":false,"given":"Charles","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"Ersan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Yousef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baltaj","family":"Sandhur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Desilets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"McGlone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smaran","family":"Teru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaapos.2024.103959_bib1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/cen.14296","article-title":"Prevalence of thyroid eye disease in Graves\u2019 disease: a meta-analysis and systematic review","volume":"93","author":"Chin","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jaapos.2024.103959_bib2","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s40618-020-01479-z","article-title":"Change in newly diagnosed Graves\u2019 disease phenotype between the twentieth and the twenty-first centuries: meta-analysis and meta-regression","volume":"44","author":"Ippolito","year":"2021","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.jaapos.2024.103959_bib3","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves\u2019 ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaapos.2024.103959_bib4","first-page":"343","article-title":"Thyroid eye disease","volume":"119","author":"Szelog","year":"2022","journal-title":"Mo Med"},{"key":"10.1016\/j.jaapos.2024.103959_bib5","first-page":"1","article-title":"Management of thyroid eye disease-related strabismus","volume":"32","author":"Akbari","year":"2020","journal-title":"J\u00a0Curr Ophthalmol"},{"issue":"Suppl_1","key":"10.1016\/j.jaapos.2024.103959_bib6","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1210\/clinem\/dgac168","article-title":"Teprotumumab and the evolving therapeutic landscape in thyroid eye disease","volume":"107","author":"Kossler","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jaapos.2024.103959_bib7","article-title":"Correlation between extraocular muscle size measured by computed tomography and the vertical angle of deviation in thyroid eye disease","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jaapos.2024.103959_bib8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/08820539909056064","article-title":"Thyroid eye disease","volume":"14","author":"Scott","year":"1999","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.jaapos.2024.103959_bib9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41433-018-0302-1","article-title":"Clinical pathophysiology of thyroid eye disease: The Cone Model","volume":"33","author":"Meyer","year":"2019","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jaapos.2024.103959_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.629925","article-title":"Stimulatory thyrotropin receptor antibodies are a biomarker for Graves\u2019 orbitopathy","volume":"11","author":"George","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jaapos.2024.103959_bib11","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 Disease","volume":"375","author":"Smith","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaapos.2024.103959_bib12","first-page":"269","article-title":"Managing strabismus in endocrine eye disease","volume":"19","author":"Skov","year":"1984","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jaapos.2024.103959_bib13","first-page":"174","article-title":"Superior oblique muscle involvement in thyroid ophthalmopathy","volume":"9","author":"Thacker","year":"2005","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.jaapos.2024.103959_bib14","first-page":"126","article-title":"Botulinum toxin injection for restrictive myopathy of thyroid-associated orbitopathy: success rate and predictive factors","volume":"20","author":"Akbari","year":"2016","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.jaapos.2024.103959_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/imj.15067","article-title":"Medical and surgical treatment of thyroid eye disease","volume":"52","author":"Hall","year":"2022","journal-title":"Intern Med J"},{"key":"10.1016\/j.jaapos.2024.103959_bib16","first-page":"67","article-title":"Treatment of thyroid ocular myopathy with adjustable and nonadjustable suture strabismus surgery","volume":"91","author":"Kraus","year":"1993","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.jaapos.2024.103959_bib17","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0002-9394(83)90062-4","article-title":"Extraocular muscle surgery for dysthyroid myopathy","volume":"95","author":"Evans","year":"1983","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaapos.2024.103959_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3928\/0191-3913-19971101-04","article-title":"Diagnosis and surgical management of strabismus associated with thyroid-related orbitopathy","volume":"34","author":"Flanders","year":"1997","journal-title":"J\u00a0Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.jaapos.2024.103959_bib19","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jaapos.2024.103959_bib20","first-page":"543","article-title":"Update on thyroid eye disease and management","volume":"3","author":"Bothun","year":"2009","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jaapos.2024.103959_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.615993","article-title":"Epidemiology, natural history, risk factors, and prevention of Graves\u2019 Orbitopathy","volume":"11","author":"Bartalena","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jaapos.2024.103959_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1530\/EJE-07-0558","article-title":"Methylprednisolone pulse therapy for patients with moderately severe Graves\u2019 orbitopathy: a prospective, randomized, placebo-controlled study","volume":"158","author":"van Geest","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jaapos.2024.103959_bib23","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1007\/s00417-023-06013-4","article-title":"Early response to intravenous methylprednisolone therapy for restrictive myopathy in patients with thyroid eye disease","volume":"261","author":"Jang","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jaapos.2024.103959_bib24","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.4049\/jimmunol.181.6.4397","article-title":"Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves\u2019 disease","volume":"181","author":"Tsui","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaapos.2024.103959_bib25","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.4049\/jimmunol.181.8.5768","article-title":"B\u00a0cells from patients with Graves\u2019 disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis","volume":"181","author":"Douglas","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaapos.2024.103959_bib26","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for thyroid-associated ophthalmopathy","volume":"376","author":"Smith","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaapos.2024.103959_bib27","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaapos.2024.103959_bib28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1089\/thy.1998.8.539","article-title":"The measurement of change in Graves\u2019 ophthalmopathy","volume":"8","author":"Gorman","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.jaapos.2024.103959_bib29","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0889-8529(18)30485-7","article-title":"Choice of therapy and criteria for assessing treatment outcome in thyroid-associated ophthalmopathy","volume":"16","author":"Bahn","year":"1987","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jaapos.2024.103959_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40123-019-00226-9","article-title":"Current understanding of the progression and management of thyroid associated orbitopathy: a systematic review","volume":"9","author":"Hodgson","year":"2020","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.jaapos.2024.103959_bib31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/eye.1998.57","article-title":"An ultrastructural and systemic analysis of glycosaminoglycans in thyroid-associated ophthalmopathy","volume":"12","author":"Pappa","year":"1998","journal-title":"Eye"},{"key":"10.1016\/j.jaapos.2024.103959_bib32","first-page":"568","article-title":"Dysthyroid optic neuropathy without extraocular muscle involvement","volume":"20","author":"Anderson","year":"1989","journal-title":"Ophthalmic Surg"},{"key":"10.1016\/j.jaapos.2024.103959_bib33","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199311113292007","article-title":"Pathogenesis of Graves\u2019 ophthalmopathy","volume":"329","author":"Bahn","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaapos.2024.103959_bib34","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1136\/bjo.80.12.1042","article-title":"Retrobulbar pressures measured during surgical decompression of the orbit","volume":"80","author":"Otto","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaapos.2024.103959_bib35","first-page":"651","article-title":"Ophthalmopathy of Graves\u2019 disease: computerized volume measurements of the orbital fat and muscle","volume":"7","author":"Forbes","year":"1986","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jaapos.2024.103959_bib36","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1177\/11206721221083836","article-title":"Outcomes and risk factors of surgical management of thyroid eye disease-related diplopia","volume":"32","author":"Laezza","year":"2022","journal-title":"Eur J Ophthalmol"},{"issue":"72","key":"10.1016\/j.jaapos.2024.103959_bib37","article-title":"Surgical treatment of strabismus in thyroid eye disease: characteristics, dose-response, and outcomes","volume":"24","author":"Honglertnapakul","year":"2020","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.jaapos.2024.103959_bib38","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.ophtha.2018.04.024","article-title":"Strabismus, strabismus surgery, and reoperation rate in the United States: analysis from the IRIS registry","volume":"125","author":"Repka","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2024.103959_bib39","article-title":"Prognostic factors of restrictive myopathy in thyroid eye disease","volume":"11","author":"Choi","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaapos.2024.103959_bib40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1507\/endocrj.40.63","article-title":"Intravenous methylprednisolone pulse therapy for Graves\u2019 ophthalmopathy","volume":"40","author":"Hiromatsu","year":"1993","journal-title":"Endocr J"},{"key":"10.1016\/j.jaapos.2024.103959_bib41","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1210\/jc.2018-01626","article-title":"Insights into local orbital immunity: evidence for the involvement of the Th17 cell pathway in thyroid-associated ophthalmopathy","volume":"104","author":"Fang","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jaapos.2024.103959_bib42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jneuroim.2008.11.010","article-title":"Changes in circulating dendritic cells and B-cells in patients with multiple sclerosis relapse during corticosteroid therapy","volume":"207","author":"Krystyna","year":"2009","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaapos.2024.103959_bib43","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jneuroim.2006.03.022","article-title":"Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: differential short-term changes on corticosteroids therapy","volume":"176","author":"Navarro","year":"2006","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaapos.2024.103959_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8896055","article-title":"Percentage of myeloid dendritic cells in peripheral venous blood is negatively related to incidence of Graves\u2019 orbitopathy","volume":"2021","author":"Wojciechowska-Durczynska","year":"2021","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jaapos.2024.103959_bib45","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1210\/jc.2009-0747","article-title":"Thyroid-associated ophthalmopathy after treatment for Graves\u2019 hyperthyroidism with antithyroid drugs or iodine-131","volume":"94","author":"Tr\u00e4isk","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jaapos.2024.103959_bib46","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","article-title":"Occurrence of ophthalmopathy after treatment for Graves\u2019 hyperthyroidism","volume":"326","author":"Tallstedt","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaapos.2024.103959_bib47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199801083380201","article-title":"Relation between therapy for hyperthyroidism and the course of Graves\u2019 ophthalmopathy","volume":"338","author":"Bartalena","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaapos.2024.103959_bib48","first-page":"185","article-title":"Thyroid receptor antibody and the development of Graves\u2019 orbitopathy: clinical experience of using radioiodine ablation in the management of Graves\u2019 orbitopathy in post-iodine ablation hypothyroid patient","volume":"11","author":"Christina","year":"2023","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"10.1016\/j.jaapos.2024.103959_bib49","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1365-2265.2003.01708.x","article-title":"TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves\u2019 ophthalmopathy patients","volume":"58","author":"Wakelkamp","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jaapos.2024.103959_bib50","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2265.1996.8220832.x","article-title":"Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption","volume":"45","author":"Pfeilschifter","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jaapos.2024.103959_bib51","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/thy.2005.15.146","article-title":"Volume changes in intra- and extraorbital compartments in patients with Graves\u2019 ophthalmopathy: effect of smoking","volume":"15","author":"Szucs-Farkas","year":"2005","journal-title":"Thyroid"},{"key":"10.1016\/j.jaapos.2024.103959_bib52","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/thy.2010.0218","article-title":"Effect of smoking on orbital fat and muscle volume in Graves\u2019 orbitopathy","volume":"21","author":"Regensburg","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.jaapos.2024.103959_bib53","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/eye.2016.184","article-title":"Effect of smoking on retrobulbar blood flow in thyroid eye disease","volume":"30","author":"Sadeghi-Tari","year":"2016","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jaapos.2024.103959_bib54","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ophtha.2021.10.017","article-title":"Teprotumumab efficacy, safety, and durability in longer-duration thyroid eye disease and re-treatment: OPTIC-X study","volume":"129","author":"Douglas","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2024.103959_bib55","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3368\/aoj.64.1.54","article-title":"Restrictive strabismus: diagnosis and management","volume":"64","author":"Flanders","year":"2014","journal-title":"Am Orthopt J"},{"key":"10.1016\/j.jaapos.2024.103959_bib56","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3368\/aoj.65.1.81","article-title":"Unmasking bilateral inferior rectus restriction in thyroid eye disease: using degree of cyclotropia","volume":"65","author":"Arnoldi","year":"2015","journal-title":"Am Orthoptic J"}],"container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853124002398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853124002398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T11:42:09Z","timestamp":1723290129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091853124002398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1091853124002398"],"URL":"https:\/\/doi.org\/10.1016\/j.jaapos.2024.103959","relation":{},"ISSN":["1091-8531"],"issn-type":[{"value":"1091-8531","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of teprotumumab infusion on ocular alignment in patients with symptomatic thyroid eye disease","name":"articletitle","label":"Article Title"},{"value":"Journal of American Association for Pediatric Ophthalmology and Strabismus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaapos.2024.103959","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Association for Pediatric Ophthalmology and Strabismus.","name":"copyright","label":"Copyright"}],"article-number":"103959"}}